Company news
Jiangsu Nhwa Pharmaceutical Co., Ltd. Class A (SZSE:002262) news
Jiangsu Nhwa Pharmaceutical Co., Ltd. Class A news releases on 6ix. Latest, Apr 18, 2026: Jiangsu Nhwa Pharmaceutical: Revenue up 3.75%, net profit down…
Press releases & updates
Jiangsu Nhwa Pharmaceutical: Revenue up 3.75%, net profit down 7.54%, strong R&D and cash flow, dividend proposed
April 17, 2026
Jiangsu Nhwa Pharmaceutical Says 2025 Net Profit Down 7.5%
April 17, 2026
Jiangsu Nhwa Pharmaceutical: Q3 2025 revenue and net profit rose 5.70% and 3.67% year-over-year, respectively
October 25, 2025
Jiangsu Nhwa Pharmaceutical Q3 Net Profit Up 3.7% Y/Y
October 24, 2025
Jiangsu Nhwa Pharmaceutical: Net profit up 11.38% year-over-year, with strong CNS drug sales and R&D growth
July 29, 2025
Jiangsu Nhwa Pharmaceutical: Q1 2025 net profit up 13.35% year-over-year on strong sales and investment returns
April 19, 2025
Jiangsu Nhwa Pharmaceutical: 2024 revenue and net profit rose double digits, with strong CNS drug and digital health growth
March 29, 2025
Jiangsu Nhwa Pharmaceutical: Q3 2024 saw double-digit revenue and profit growth, with robust cash flow and rising EPS
October 24, 2024
Jiangsu Nhwa Pharmaceutical: H1 revenue and net profit rose 15%+ on CNS drug growth and robust R&D pipeline
July 29, 2024